Incyte Corporation (INCY) Financials

INCY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 7.3 billion 1.8 billion
Dec. 31, 2025 7.0 billion 1.8 billion
Sept. 30, 2025 6.3 billion 1.7 billion
June 30, 2025 5.8 billion 1.7 billion

INCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 359.2 million 64.1 million
Dec. 31, 2025 521.4 million 62.2 million
Sept. 30, 2025 544.6 million 61.6 million
June 30, 2025 25.7 million 64.6 million

INCY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 303.3 million
Dec. 31, 2025 299.3 million
Sept. 30, 2025 424.2 million
June 30, 2025 405.0 million

INCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.0 billion - 33.8 million
Dec. 31, 2025 3.6 billion 14.5 million 44.7 million
Sept. 30, 2025 2.9 billion - 30.9 million
June 30, 2025 2.4 billion - 42.4 million

INCY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 206.8 million
Dec. 31, 2025 204.8 million
Sept. 30, 2025 201.4 million
June 30, 2025 198.7 million

INCY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 10.2 million 515.9 million 328.1 million 328.1 million
Dec. 31, 2025 21.9 million 595.2 million 390.4 million -
Sept. 30, 2025 14.7 million 506.6 million 329.1 million -
June 30, 2025 19.1 million 478.0 million 331.0 million -

INCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.3 billion 104.5 million
Dec. 31, 2025 1.5 billion 137.4 million
Sept. 30, 2025 1.4 billion 99.0 million
June 30, 2025 1.2 billion 95.7 million

INCY Revenue by Segment
Graph available only for paid members. Upgrade to see it.

INCY

Price: $97.98

52 week price:
57.77
112.29

Earnings Per Share: 7.10 USD

P/E Ratio: 13.68

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Ebitda: -135.0 million

Market Capitalization: 19.9 billion

Links: